DescriptionIndicationsContraIndicationsDosageWarning/PrecautionsBioequivalence

DOPANORE TABLETS

DESCRIPTION

Introduction

METHYLDOPA

Methyl dopa is a widely used oral antihypertensive agent. XX is analog of L-dopa. Chemically XX is identified as L-3-(3, 4-dihydroxyphenyl)-2-methylalanine. After crossing the blood-brain barrier, XX is decarboxylated to produce alpha-methylnorepinephrine. This metabolite stimulates central inhibitory alpha-adrenergic receptors, thereby reducing peripheral resistance and lowering blood pressure.it also may act as a false transmitter, thereby exerting a direct effect on peripheral sympathetic nerves. Blood pressure decreases are greatest when the patient is standing but are also significant when the patient is supine. Postural hypotension has been reported in patients receiving it. It can cause sodium and fluid retention, and tolerance can develop during long-term therapy.

Category:

  • Cardiovascular drugs
  • Anti-hypertensives
  • Centrally acting sympathoplegic drugs

Primary Characterstics

Methyldopa is of Synthetic origin and belongs to Phenyl Alanine. It belongs to Alpha-2 adrenergic agonist pharmacological group on the basis of mechanism of action and also classified in Antihypertensive Agents pharmacological group.The Molecular Weight of Methyldopa is 238.20.
Its pKa is 2.2, 9.2, 10.6, 12.

Pharmacokinetics

Volume of distribution is found to be 0.4 -0.7 l/kg and plasma protien binding is 10-15%. Presystemic metabolism is noted to be 65% ±25 and metabolism is reported Hepatic & Small Intestine. Renal Excretion accounts for 50% and plasma half life is 1-2 hr.